文献速递骨软组织肉瘤与黑色素瘤

原发四肢软组织肉瘤肿瘤学结局的年龄相关差异:纳入6260例患者的多状态模型

Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients.
PubMed 文献 · Eur J Cancer · 2020-10-30

该回顾性多中心研究纳入2000至2016年间接受根治性手术的6260例18岁以上原发高级别四肢软组织肉瘤患者,比较青年(18-39岁)、中年(40-69岁)和老年(≥70岁)人群的总体生存和疾病进展。校正肿瘤特征和治疗变量不平衡后,中年和老年患者的总生存风险比分别为1.47(95%CI 1.23-1.76)和3.13(95%CI 2.59-3.78),年龄对总生存的影响仅能部分由肿瘤特征和治疗差异解释。

要点

  • 老年高级别四肢软组织肉瘤患者总生存风险约为青年的3倍,部分归因于其他原因死亡率更高。
  • 青年患者更多表现为「whoops」手术后或残留病灶再切除,且深部肿瘤更多。
  • 老年患者更多表现为III级和较大(≥10 cm)肿瘤。

核心结论

  • 年龄对总生存的影响仅能部分由肿瘤特征和治疗变量不平衡解释,老年患者风险约为青年的3倍,至少部分归因于其他原因死亡率更高。

研究设计与样本

  • 回顾性多中心研究,纳入2000至2016年间接受根治性手术的6260例18岁以上原发高级别四肢软组织肉瘤患者。
  • 使用Cox比例风险模型和多状态模型分析年龄与总生存及疾病进展的关联。

主要发现

  • 青年患者更多表现为「whoops」手术后或残留病灶再切除,且深部肿瘤更多。
  • 老年患者更多表现为III级和较大(≥10 cm)肿瘤。
  • 校正肿瘤和治疗特征不平衡后,中年患者总生存风险比为1.47(95%CI 1.23-1.76),老年患者为3.13(95%CI 2.59-3.78),均以青年为参照。

临床怎么用

  • 临床评估高级别四肢软组织肉瘤患者时需考虑年龄相关的肿瘤特征和治疗差异对预后的影响。
  • 老年患者总生存较差部分由其他原因死亡率解释,提示需综合评估合并症和个体化治疗。

局限性

  • 年龄对总生存的影响仅能部分由肿瘤特征和治疗变量解释,残余混杂可能影响结果。
  • 老年患者风险较高可能部分归因于肿瘤行为差异或治疗不理想,但研究未明确区分。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: No studies extensively compared the young adults (YA, 18-39 years), middle-aged (40-69 years), and elderly (≥70 years) population with primary high-grade extremity soft tissue sarcoma (eSTS). This study aimed to determine whether the known effect of age on overall survival (OS) and disease progression can be explained by differences in tumour characteristics and treatment protocol among the YA, middle-aged and elderly population in patients with primary high-grade eSTS treated with curative intent. METHODS: In this retrospective multicentre study, inclusion criteria were patients with primary high-grade eSTS of 18 years and older, surgically treated with curative intent between 2000 and 2016. Cox proportional hazard models and a multistate model were used to determine the association of age on OS and disease progression. RESULTS: A total of 6260 patients were included in this study. YA presented more often after 'whoops'-surgery or for reresection due to residual disease, and with more deep-seated tumours. Elderly patients presented more often with grade III and larger (≥10 cm) tumours. After adjustment for the imbalance in tumour and treatment characteristics the hazard ratio for OS of the middle-aged population is 1.47 (95% confidence interval [CI]: 1.23-1.76) and 3.13 (95% CI: 2.59-3.78) in the elderly population, compared with YA. DISCUSSION: The effect of age on OS could only partially be explained by the imbalance in the tumour characteristics and treatment variables. The threefold higher risk of elderly could, at least partially, be explained by a higher other-cause mortality. The results might also be explained by a different tumour behaviour or suboptimal treatment in elderly compared with the younger population.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. Acem I, Verhoef C, Rueten-Budde AJ, et al. Age-related differences of oncological outcomes in primary extremity soft tissue sarcoma: a multistate model including 6260 patients. Eur J Cancer. 2020. PMID: 33137588. doi:10.1016/j.ejca.2020.09.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。